ArticleBlood advances2021

IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB- and caspase-8-dependent mechanisms.

Liang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.